StockNews.com Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) to Sell

StockNews.com lowered shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Rating) from a hold rating to a sell rating in a research report report published on Saturday. MDGL has been the subject of a number of other research reports. Canaccord Genuity Group raised their price objective on Madrigal Pharmaceuticals from $296.00 to $336.00 and gave the […]

Related Keywords

,Vanguard Group Inc ,News Ratings For Madrigal Pharmaceuticals Daily ,Armistice Capital ,Madrigal Pharmaceuticals Trading ,Canaccord Genuity Group ,Madrigal Pharmaceuticals Company Profile ,Hedge Funds Weigh In On Madrigal Pharmaceuticals ,Avoro Capital Advisors ,Analyst Recommendations For Madrigal Pharmaceuticals ,Blackrock Inc ,Madrigal Pharmaceuticals ,Madrigal Pharmaceuticals Inc ,Get Rating ,Genuity Group ,Moderate Buy ,Capital Advisors ,Street Corp ,Madrigal Pharmaceuticals Daily ,Nasdaq Mdgl ,Mdgl ,Medical ,87162t20 ,Downgrade ,Stocknews Com ,